These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 11192920)

  • 21. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer.
    Danielson H; Kokkola A; Kiviluoto T; Sirén J; Louhimo J; Kivilaakso E; Puolakkainen P
    Scand J Surg; 2007; 96(1):35-40. PubMed ID: 17461310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes after D2 gastrectomy for early gastric cancer: survival analysis of a single-center experience in China.
    Wang Z; Ma L; Zhang XM; Zhou ZX
    Asian Pac J Cancer Prev; 2014; 15(17):7219-22. PubMed ID: 25227817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of D2 gastrectomy for gastric cancer: lymph node chain dissection or multiple node resection?
    Zilberstein B; Mucerino DR; Yagi OK; Ribeiro-Junior U; Lopasso FP; Bresciani C; Jacob CE; Coimbra BG; Cecconello I
    Arq Bras Cir Dig; 2012; 25(3):161-4. PubMed ID: 23411804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
    Roukos DH; Lorenz M; Encke A
    Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
    Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
    World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modified radical lymphadenectomy (D1.5) for T2-3 gastric cancer.
    Ichikura T; Chochi K; Sugasawa H; Mochizuki H
    Langenbecks Arch Surg; 2005 Sep; 390(5):397-402. PubMed ID: 16041552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study.
    Rausei S; Ruspi L; Rosa F; Morgagni P; Marrelli D; Cossu A; Cananzi FC; Lomonaco R; Coniglio A; Biondi A; Cipollari C; Graziosi L; Fumagalli U; Casella F; Bertoli P; di Leo A; Alfieri S; Vittimberga G; Roviello F; Orsenigo E; Quagliuolo V; Montemurro S; Baiocchi G; Persiani R; Bencivenga M; Donini A; Rosati R; Sansonetti A; Ansaloni L; Zanoni A; Galli F; Dionigi G;
    Eur J Surg Oncol; 2016 Dec; 42(12):1881-1889. PubMed ID: 27266816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of spleen-preserving lymphadenectomy in total gastrectomy for gastric and esophagogastric junctional adenocarcinomas: A long-term retrospective propensity score match study from a high-volume institution in China.
    Liu K; Chen XZ; Zhang YC; Zhang WH; Chen XL; Sun LF; Yang K; Zhang B; Zhou ZG; Hu JK
    Surgery; 2021 Feb; 169(2):426-435. PubMed ID: 32950240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival benefit of D2 lympadenectomy in patients with gastric adenocarcinoma.
    Oñate-Ocaña LF; Aiello-Crocifoglio V; Mondragón-Sánchez R; Ruiz-Molina JM
    Ann Surg Oncol; 2000 Apr; 7(3):210-7. PubMed ID: 10791852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery.
    Roukos DH; Paraschou P; Lorenz M
    Ann Surg Oncol; 2000 Dec; 7(10):719-26. PubMed ID: 11129418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial.
    de Steur WO; Hartgrink HH; Dikken JL; Putter H; van de Velde CJ
    Br J Surg; 2015 Oct; 102(11):1388-93. PubMed ID: 26313463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study.
    Roviello F; Marrelli D; Morgagni P; de Manzoni G; Di Leo A; Vindigni C; Saragoni L; Tomezzoli A; Kurihara H;
    Ann Surg Oncol; 2002 Nov; 9(9):894-900. PubMed ID: 12417512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WITHDRAWN: Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.
    McCulloch P; Nita ME; Kazi H; Gama-Rodrigues JJ
    Cochrane Database Syst Rev; 2012 Jan; 1():CD001964. PubMed ID: 22258947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.
    McCulloch P; Nita ME; Kazi H; Gama-Rodrigues J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD001964. PubMed ID: 15495024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastasis in para-aortic lymph nodes in patients with advanced gastric cancer, treated with extended lymphadenectomy.
    Yonemura Y; Wu CC; Fukushima N; Honda I; Bandou E; Kawamura T; Kamata S; Yamamoto H; Kim BS; Matsuki N; Sawa T; Noh SH;
    Hepatogastroenterology; 2007 Mar; 54(74):634-8. PubMed ID: 17523339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
    Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
    J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer?
    Biondi A; D'Ugo D; Cananzi FC; Papa V; Borasi A; Sicoli F; Degiuli M; Doglietto G; Persiani R
    Eur J Surg Oncol; 2015 Jun; 41(6):779-86. PubMed ID: 25899981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastric carcinoma: does lymph node dissection alter survival?
    Wanebo HJ; Kennedy BJ; Winchester DP; Fremgen A; Stewart AK
    J Am Coll Surg; 1996 Dec; 183(6):616-24. PubMed ID: 8957465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma.
    Memon MA; Subramanya MS; Khan S; Hossain MB; Osland E; Memon B
    Ann Surg; 2011 May; 253(5):900-11. PubMed ID: 21394009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival prognosis and clinicopathological features of the lymph nodes along the left gastric artery in gastric cancer: implications for D2 lymphadenectomy.
    Chen JH; Cai SR; Zhai ET; Chen SL; Wu KM; Song W; He YL
    Int J Clin Exp Pathol; 2015; 8(11):14365-73. PubMed ID: 26823752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.